Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$163.63
+0.3%
$158.68
$140.68
$169.99
$394.32B0.477.63 million shs5.76 million shs
Morgan Stanley stock logo
MS
Morgan Stanley
$115.23
-3.2%
$129.61
$85.01
$142.03
$185.85B1.356.53 million shs7.35 million shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.97%+0.18%-1.75%+12.52%+3.33%
Morgan Stanley stock logo
MS
Morgan Stanley
-2.46%-1.10%-8.03%-5.99%+27.45%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.4036 of 5 stars
2.33.04.23.93.52.50.6
Morgan Stanley stock logo
MS
Morgan Stanley
4.8468 of 5 stars
3.23.04.22.43.42.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.56
Moderate Buy$171.334.71% Upside
Morgan Stanley stock logo
MS
Morgan Stanley
2.33
Hold$131.5314.15% Upside

Current Analyst Ratings Breakdown

Latest JNJ and MS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/28/2025
Morgan Stanley stock logo
MS
Morgan Stanley
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$142.00 ➝ $130.00
3/25/2025
Morgan Stanley stock logo
MS
Morgan Stanley
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$124.00 ➝ $129.00
3/24/2025
Morgan Stanley stock logo
MS
Morgan Stanley
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$135.00 ➝ $125.00
3/19/2025
Morgan Stanley stock logo
MS
Morgan Stanley
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$144.00 ➝ $126.00
3/17/2025
Morgan Stanley stock logo
MS
Morgan Stanley
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
3/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$159.00 ➝ $171.00
2/19/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.00
2/3/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$162.00 ➝ $166.00
1/28/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$159.00 ➝ $166.00
1/24/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 3/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.44$13.45 per share12.17$29.69 per share5.51
Morgan Stanley stock logo
MS
Morgan Stanley
$57.62B3.23$7.22 per share15.97$55.58 per share2.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$6.6524.6114.782.5618.20%34.24%13.63%4/15/2025 (Estimated)
Morgan Stanley stock logo
MS
Morgan Stanley
$13.39B$7.9414.5112.221.1812.48%14.39%1.09%4/15/2025 (Estimated)

Latest JNJ and MS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/15/2025N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59N/AN/AN/A$21.65 billionN/A
4/15/2025N/A
Morgan Stanley stock logo
MS
Morgan Stanley
$2.22N/AN/AN/A$16.81 billionN/A
1/22/2025Q4 2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billion
1/16/2025Q4 24
Morgan Stanley stock logo
MS
Morgan Stanley
$1.54$2.22+$0.68$2.22$15.03 billion$16.23 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.963.03%+5.43%74.59%63 Years
Morgan Stanley stock logo
MS
Morgan Stanley
$3.703.21%+19.13%46.60%12 Years

Latest JNJ and MS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.43%2/18/20252/18/20253/4/2025
1/16/2025
Morgan Stanley stock logo
MS
Morgan Stanley
quarterly$0.92502.82%1/31/20251/31/20252/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.43
1.11
0.86
Morgan Stanley stock logo
MS
Morgan Stanley
3.14
0.80
0.80

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Morgan Stanley stock logo
MS
Morgan Stanley
84.19%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Morgan Stanley stock logo
MS
Morgan Stanley
0.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
152,7002.41 billion2.40 billionOptionable
Morgan Stanley stock logo
MS
Morgan Stanley
82,4001.61 billion1.61 billionOptionable

Recent News About These Companies

10 Best Mid Cap AI Stocks to Buy Now
Insider Sale: President of $DRI Sells 2,289 Shares
Morgan Stanley Announces Departure of Key Executive
Morgan Stanley sells 19 lakh shares worth Rs 81 lakh in this penny stock
New Analyst Forecast: $MTB Given 'Neutral' Rating
New Analyst Forecast: $NFLX Given 'Hold' Rating
New Analyst Forecast: $DB Given 'Outperform' Rating
New Analyst Forecast: $VIK Given 'Outperform' Rating
New Analyst Forecast: $BK Given 'Neutral' Rating
New Analyst Forecast: $WMG Given 'Sector Perform' Rating
New Analyst Forecast: $THC Given 'Overweight' Rating

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$163.63 +0.50 (+0.31%)
Closing price 03:59 PM Eastern
Extended Trading
$163.36 -0.27 (-0.17%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Morgan Stanley stock logo

Morgan Stanley NYSE:MS

$115.23 -3.77 (-3.17%)
Closing price 03:59 PM Eastern
Extended Trading
$114.80 -0.43 (-0.37%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.